Metrion Biosciences Limited, a specialist ion channel contract research and drug discovery company, has appointed Nick Foster as chief commercial officer and head of Global Business Development, to support the broadening of Metrion’s international customer base and facilitate entry into new territories.   The appointment follows the recently announced £2.7 million ($3.73 million) new equity investment led by Gresham House Ventures and forms part of the Company’s significant growth strategy for 2...